Greg Matlashewski
Greg Matlashewski
Verified email at
Cited by
Cited by
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
A Storey, M Thomas, A Kalita, C Harwood, D Gardiol, F Mantovani, ...
Nature 393 (6682), 229-234, 1998
Two polymorphic variants of wild-type p53 differ biochemically and biologically
M Thomas, A Kalita, S Labrecque, D Pim, L Banks, G Matlashewski
Molecular and cellular biology 19 (2), 1092-1100, 1999
Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
European journal of biochemistry 159 (3), 529-534, 1986
Primary structure polymorphism at amino acid residue 72 of human p53
GJ Matlashewski, S Tuck, D Pim, P Lamb, J Schneider, LV Crawford
Molecular and cellular biology 7 (2), 961-963, 1987
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.
G Matlashewski, J Schneider, L Banks, N Jones, A Murray, L Crawford
The EMBO journal 6 (6), 1741-1746, 1987
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
G Matlashewski, P Lamb, D Pim, J Peacock, L Crawford, S Benchimol
The EMBO journal 3 (13), 3257-3262, 1984
Intracellular infection by Leishmania donovani inhibits macrophage apoptosis.
KJ Moore, G Matlashewski
The Journal of Immunology 152 (6), 2930-2937, 1994
Mechanisms of p53 loss in human sarcomas.
LM Mulligan, GJ Matlashewski, HJ Scrable, WK Cavenee
Proceedings of the National Academy of Sciences 87 (15), 5863-5867, 1990
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α
S Li, S Labrecque, MC Gauzzi, AR Cuddihy, AHT Wong, S Pellegrini, ...
Oncogene 18 (42), 5727-5737, 1999
The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus.
P Leechanachai, L Banks, F Moreau, G Matlashewski
Oncogene 7 (1), 19-25, 1992
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh, D Stewart, G Matlashewski
Molecular and cellular biology 24 (18), 7987-7997, 2004
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo, B Ward, R Miller, TC Meng, E Najar, E Alvarez, G Matlashewski, ...
Clinical infectious diseases 33 (11), 1847-1851, 2001
p53 polymorphism and risk of cervical cancer
A Storey, M Thomas, A Kalita, C Harwood, D Gardiol, F Mantovani, ...
Nature 396 (6711), 532-532, 1998
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania …
EAF Coelho, CAP Tavares, FAA Carvalho, KF Chaves, KN Teixeira, ...
Infection and Immunity 71 (7), 3988-3994, 2003
Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action
S Buates, G Matlashewski
The Journal of infectious diseases 179 (6), 1485-1494, 1999
The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression
V Bouvard, G Matlashewski, ZM Gu, A Storey, L Banks
Virology 203 (1), 73-80, 1994
Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan.
A Descoteaux, G Matlashewski, SJ Turco
The Journal of Immunology 149 (9), 3008-3015, 1992
Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections
A Ghosh, WW Zhang, G Matlashewski
Vaccine 20 (1-2), 59-66, 2001
Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene
H Charest, G Matlashewski
Molecular and cellular biology 14 (5), 2975-2984, 1994
Determinants for the development of visceral leishmaniasis disease
LI McCall, WW Zhang, G Matlashewski
PLoS pathogens 9 (1), e1003053, 2013
The system can't perform the operation now. Try again later.
Articles 1–20